Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CH5N3O |
| Molecular Weight | 75.0699 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NO
InChI
InChIKey=WFBHRSAKANVBKH-UHFFFAOYSA-N
InChI=1S/CH5N3O/c2-1(3)4-5/h5H,(H4,2,3,4)
| Molecular Formula | CH5N3O |
| Molecular Weight | 75.0699 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| EPR and ENDOR characterization of intermediates in the cryoreduced oxy-nitric oxide synthase heme domain with bound L-arginine or N(G)-hydroxyarginine. | 2002 Aug 20 |
|
| Ceramide binding to African-American hair fibre correlates with resistance to hair breakage. | 2002 Feb |
|
| Novel substrates for nitric oxide synthases. | 2002 Sep |
|
| [Metalloporphyrin catalyzed biomimetic oxidation potentials: potential uses and applications]. | 2003 |
|
| Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode. | 2003 Apr 8 |
|
| pH-dependent stability of sperm whale myoglobin in water-guanidine hydrochloride solutions. | 2003 Feb |
|
| The mechanism of L-canavanine cytotoxicity: arginyl tRNA synthetase as a novel target for anticancer drug discovery. | 2003 Oct |
|
| Reactivity of the heme-dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates. | 2006 Jan |
|
| Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay. | 2008 Apr |
|
| Synthesis of (+)- and (-)-monanchorin. | 2009 Feb 19 |
|
| N-Hydroxyguanidines oxidation by a N3S copper-complex mimicking the reactivity of Dopamine beta-Hydroxylase. | 2009 Mar |
|
| Reaction of N-hydroxyguanidine with the ferrous-oxy state of a heme peroxidase cavity mutant: a model for the reactions of nitric oxide synthase. | 2010 Aug 1 |
|
| Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif. | 2010 Feb 25 |
|
| Dimerization of protegrin-1 in different environments. | 2010 Sep 9 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:12:19 GMT 2023
by
admin
on
Fri Dec 15 18:12:19 GMT 2023
|
| Record UNII |
8767F421T7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
529357
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
43089
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
DB03770
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
DTXSID00156915
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
80668
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
8767F421T7
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY | |||
|
13115-21-4
Created by
admin on Fri Dec 15 18:12:19 GMT 2023 , Edited by admin on Fri Dec 15 18:12:19 GMT 2023
|
PRIMARY |